OMER

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Omeros Corporation

NASDAQ | OMER

7.77

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 24, 2025)

$526.75M

Market Cap

-

P/E Ratio

-2.36

EPS

$13.60

52 Week High

$2.95

52 Week Low

HEALTHCARE

Sector

OMER Chart

Recent Chart
Price Action

OMER Technicals

Tags:

OMER Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$950K
Total Revenue $0
Cost Of Revenue $950K
Costof Goods And Services Sold $950K
Operating Income -$169M
Selling General And Administrative $50M
Research And Development $120M
Operating Expenses $169M
Investment Income Net -
Net Interest Income -$13M
Interest Income $11M
Interest Expense $25M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $950K
Income Before Tax -$157M
Income Tax Expense $26M
Interest And Debt Expense -
Net Income From Continuing Operations -$183M
Comprehensive Income Net Of Tax -
Ebit -$158M
Ebitda -$157M
Net Income -$157M

Revenue & Profitability

Earnings Performance

OMER Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $277M
Total Current Assets $134M
Cash And Cash Equivalents At Carrying Value $3.4M
Cash And Short Term Investments $3.4M
Inventory -
Current Net Receivables $37M
Total Non Current Assets $143M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $87M
Other Current Assets $7.2M
Other Non Current Assets -
Total Liabilities $460M
Total Current Liabilities $80M
Current Accounts Payable $5.9M
Deferred Revenue -
Current Debt -
Short Term Debt $27M
Total Non Current Liabilities $380M
Capital Lease Obligations $19M
Long Term Debt $167M
Current Long Term Debt $21M
Long Term Debt Noncurrent -
Short Long Term Debt Total $207M
Other Current Liabilities $47M
Other Non Current Liabilities $196M
Total Shareholder Equity -$183M
Treasury Stock -
Retained Earnings -$910M
Common Stock $580K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$149M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $950K
Capital Expenditures $165K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $82M
Cashflow From Financing $63M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$12M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$157M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$950K
Total Revenue $0
Cost Of Revenue $950K
Costof Goods And Services Sold $950K
Operating Income -$169M
Selling General And Administrative $50M
Research And Development $120M
Operating Expenses $169M
Investment Income Net -
Net Interest Income -$13M
Interest Income $11M
Interest Expense $25M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $950K
Income Before Tax -$157M
Income Tax Expense $26M
Interest And Debt Expense -
Net Income From Continuing Operations -$183M
Comprehensive Income Net Of Tax -
Ebit -$158M
Ebitda -$157M
Net Income -$157M

OMER News

OMER Profile

Omeros Corporation Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Omeros Corporation is a Seattle-based biopharmaceutical firm that specializes in the discovery, development, and commercialization of novel therapeutics aimed at serious conditions. The company boasts a diverse pipeline featuring both protein and small molecule therapies, targeting critical unmet medical needs in areas such as inflammation, complement-mediated diseases, and central nervous system (CNS) disorders. With a strategic focus on orphan indications, Omeros is well-equipped to drive growth and make significant advancements in patient care, positioning itself as a leader in innovative treatment solutions.

WGRX
+252.44%
$1.42
YYAI
-15.73%
$0.07
BYND
+8.08%
$3.06
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
VIVK
+25.55%
$0.32
YDKG
-19.77%
$0.05
QBTS
+13.81%
$31.06
BITF
+5.71%
$4.16
WTO
-7.04%
$0.06
INTC
+3.35%
$39.44
AREB
+75.34%
$3.77
NEUP
+52.46%
$6.17
AXDX
-61.36%
$0.03
ADTX
+2.70%
$0.30
VZ
-3.51%
$38.40
BURU
+3.07%
$0.35
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
QLGN
+44.75%
$5.11
SCNX
-35.00%
$1.69
GPUS
-0.28%
$0.38
SRM
+53.27%
$10.30
AMZN
+1.44%
$221.09
AMD
+7.54%
$252.72
AAL
+6.45%
$13.59
CUTR
-10.19%
$0.09
DVLT
+15.10%
$2.58
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
SCWO
+32.07%
$0.48
ETWO
0.00%
$3.30
BTE
+5.72%
$2.40
VALE
-0.52%
$11.46
RIG
+4.11%
$4.05
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
KDLY
+10.41%
$0.79
BMNR
+2.41%
$49.19
NOK
+0.32%
$6.18
F
+7.20%
$13.22
RANI
-13.45%
$2.09
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
KLG
-9.05%
$13.35
RGTI
+7.39%
$42.52
GRYP
-10.38%
$1.38
CAN
+4.26%
$1.83
MODV
-25.22%
$0.43
LXEH
+24.60%
$0.56
OKLO
+3.81%
$124.70
ASST
+10.78%
$0.86
IBM
-0.87%
$285.00
EOSE
-4.64%
$14.36
NRXS
-7.72%
$3.52
AMC
-1.46%
$2.69
NBIS
+7.64%
$106.16
PLTR
+2.45%
$184.91
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
IONZ
-9.04%
$3.62
ZAPP
-46.30%
$0.15
CIFR
+12.19%
$19.36
PLUG
+3.77%
$2.98
KDP
+0.58%
$27.55
NGD
+0.62%
$6.46
NUAI
+18.73%
$4.69
DNN
+1.09%
$2.76
WMT
-0.26%
$106.86
NIO
-0.21%
$6.87
IAG
-0.08%
$12.04
RXRX
+0.61%
$5.76
NEHC
+4.22%
$3.95
ADAP
+0.85%
$0.07
BREA
+36.64%
$11.41
RR
+5.53%
$5.72
ABEV
+0.67%
$2.22
SMR
+3.72%
$38.95
MSAI
-46.40%
$0.72
SOC
+18.61%
$14.02
ACHR
+3.22%
$11.26
BBD
-0.14%
$3.34
TLRY
+0.76%
$1.49
HOOD
+3.78%
$139.41
TGB
+5.15%
$4.08
RVPH
+7.10%
$0.60
MU
+4.65%
$216.33
IMG
+3.79%
$0.23
DEFT
-1.47%
$2.00
UUUU
+0.23%
$21.31
ONDS
+9.27%
$7.71
CAG
-1.65%
$18.47
T
+0.52%
$24.74
HTZ
+4.84%
$5.19
BP
+1.98%
$35.00
LUMN
+5.71%
$8.23
SOFI
+5.09%
$29.51
PMI
-69.69%
$4.00
PSTV
+7.68%
$0.63
WGRX
+252.44%
$1.42
YYAI
-15.73%
$0.07
BYND
+8.08%
$3.06
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
VIVK
+25.55%
$0.32
YDKG
-19.77%
$0.05
QBTS
+13.81%
$31.06
BITF
+5.71%
$4.16
WTO
-7.04%
$0.06
INTC
+3.35%
$39.44
AREB
+75.34%
$3.77
NEUP
+52.46%
$6.17
AXDX
-61.36%
$0.03
ADTX
+2.70%
$0.30
VZ
-3.51%
$38.40
BURU
+3.07%
$0.35
QS
+7.95%
$14.66
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
QLGN
+44.75%
$5.11
SCNX
-35.00%
$1.69
GPUS
-0.28%
$0.38
SRM
+53.27%
$10.30
AMZN
+1.44%
$221.09
AMD
+7.54%
$252.72
AAL
+6.45%
$13.59
CUTR
-10.19%
$0.09
DVLT
+15.10%
$2.58
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
SCWO
+32.07%
$0.48
ETWO
0.00%
$3.30
BTE
+5.72%
$2.40
VALE
-0.52%
$11.46
RIG
+4.11%
$4.05
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
KDLY
+10.41%
$0.79
BMNR
+2.41%
$49.19
NOK
+0.32%
$6.18
F
+7.20%
$13.22
RANI
-13.45%
$2.09
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
KLG
-9.05%
$13.35
RGTI
+7.39%
$42.52
GRYP
-10.38%
$1.38
CAN
+4.26%
$1.83
MODV
-25.22%
$0.43
LXEH
+24.60%
$0.56
OKLO
+3.81%
$124.70
ASST
+10.78%
$0.86
IBM
-0.87%
$285.00
EOSE
-4.64%
$14.36
NRXS
-7.72%
$3.52
AMC
-1.46%
$2.69
NBIS
+7.64%
$106.16
PLTR
+2.45%
$184.91
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
IONZ
-9.04%
$3.62
ZAPP
-46.30%
$0.15
CIFR
+12.19%
$19.36
PLUG
+3.77%
$2.98
KDP
+0.58%
$27.55
NGD
+0.62%
$6.46
NUAI
+18.73%
$4.69
DNN
+1.09%
$2.76
WMT
-0.26%
$106.86
NIO
-0.21%
$6.87
IAG
-0.08%
$12.04
RXRX
+0.61%
$5.76
NEHC
+4.22%
$3.95
ADAP
+0.85%
$0.07
BREA
+36.64%
$11.41
RR
+5.53%
$5.72
ABEV
+0.67%
$2.22
SMR
+3.72%
$38.95
MSAI
-46.40%
$0.72
SOC
+18.61%
$14.02
ACHR
+3.22%
$11.26
BBD
-0.14%
$3.34
TLRY
+0.76%
$1.49
HOOD
+3.78%
$139.41
TGB
+5.15%
$4.08
RVPH
+7.10%
$0.60
MU
+4.65%
$216.33
IMG
+3.79%
$0.23
DEFT
-1.47%
$2.00
UUUU
+0.23%
$21.31
ONDS
+9.27%
$7.71
CAG
-1.65%
$18.47
T
+0.52%
$24.74
HTZ
+4.84%
$5.19
BP
+1.98%
$35.00
LUMN
+5.71%
$8.23
SOFI
+5.09%
$29.51
PMI
-69.69%
$4.00
PSTV
+7.68%
$0.63
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.